Awakn CEO Anthony Tennyson Predicts 2022 Will Be A Big Year For Institutional Investment In Psychedelics Dec 9, 2021
MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System Dec 9, 2021
By The Numbers: Consumer Highlights From Weedmaps’ First-Ever Cannabis Data & Insights Report Dec 8, 2021
Cybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate… Dec 8, 2021
